Hypothyroidism: Difference between revisions
Line 161: | Line 161: | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |TPOAb | ! align="center" style="background: #4479BA; color: #FFFFFF; " |TPOAb | ||
|- | |- | ||
| rowspan=" | | rowspan="3" style="background:#DCDCDC;" |Primary hypothyroidism | ||
| align="center" style="background:#DCDCDC;" |Autoimmune | | align="center" style="background:#DCDCDC;" |Autoimmune | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | ||
Line 181: | Line 181: | ||
| align="center" style="background:#DCDCDC;" |Thyroiditis | | align="center" style="background:#DCDCDC;" |Thyroiditis | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |+/- | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/- | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''''↓''''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal or ↓ | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 194: | Line 194: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |Others | | align="center" style="background:#DCDCDC;" |Others | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
Line 201: | Line 200: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''''↓''''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal or ↓ | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 217: | Line 216: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |''''''''↓'''''''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
Line 355: | Line 354: | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " | HEENT | ! align="center" style="background: #4479BA; color: #FFFFFF; " | HEENT | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |Neuromuscular | ! align="center" style="background: #4479BA; color: #FFFFFF; " |Neuromuscular | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |Complications | ! align="center" style="background: #4479BA; color: #FFFFFF; " |Complications | ||
|- | |- | ||
| align="center" style="background: #DCDCDC; " | | align="center" style="background: #DCDCDC; " |More common | ||
| | | | ||
* Cold intolerance | * Cold intolerance | ||
Line 364: | Line 362: | ||
* Hypothermia | * Hypothermia | ||
* Weight gain | * Weight gain | ||
* Constipation | |||
| | | | ||
* Hoarseness | * Hoarseness | ||
Line 372: | Line 371: | ||
* Emotional lability | * Emotional lability | ||
* Attention deficit | * Attention deficit | ||
| | | | ||
* Macroglossia | * Macroglossia | ||
Line 381: | Line 378: | ||
* Blurred vision (central hypothyroidism) | * Blurred vision (central hypothyroidism) | ||
|- | |- | ||
| align="center" style="background: #DCDCDC; " | | align="center" style="background: #DCDCDC; " |Less common | ||
| | | | ||
* Puffiness | * Puffiness | ||
* | * Coarse skin | ||
* | * Coarse, brittle, straw like hair with hair loss | ||
* Fever if accompanied by thyroiditis | * Fever if accompanied by thyroiditis | ||
| | | | ||
Line 392: | Line 389: | ||
| | | | ||
* Slowed speech and movements | * Slowed speech and movements | ||
| | | | ||
* Pituitary hyperplasia followed by hyperprolactinoma | * Pituitary hyperplasia followed by hyperprolactinoma | ||
Line 400: | Line 396: | ||
* Pericardial effusion | * Pericardial effusion | ||
* Ascites | * Ascites | ||
* | * Hyperlipidemia | ||
* Galactorrhea | * Galactorrhea | ||
* Infertility | * Infertility | ||
|} | |} | ||
* | ** | ||
* | |||
==Screening== | ==Screening== |
Revision as of 16:23, 13 July 2017
For patient information click here
Hypothyroidism Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
Synonyms and keywords: Myxedema; myxoedema; thyroid activity decreased; hypothyroid
Overview
Environmental iodine deficiency is the most common cause of hypothyroidism on a worldwide basis (16). In areas of iodine sufficiency, such as the United States, the most common cause of hypothyroidism is chronic autoimmune thyroiditis (Hashimoto’s thyroiditis).Autoimmune thyroid diseases (AITDs) have been estimated to be 5-10 times more common in women than in men.
Classification
The table below presents a classification of isolated thyroid disorders and its causes based on the classification:
Origin of the defect | Causes | ||||||
---|---|---|---|---|---|---|---|
Endagenous causes | Exagenous causes | ||||||
Thyroid | Pituirtary | Hypothalamus | Surgery or radiation | Other causes | |||
Primary hypothyroidism | + | - | - |
|
|
| |
Transient hypothyroidism | + | + | - |
|
|
||
Central Hypothyroidism | Secondary
OR Pituitary originated |
- | + | - |
|
|
|
Tertiary
OR Hypothalamus originated |
- | - | + |
|
|
|
Classification of thyroiditis based on the duration algorythm
History, signs, and symptoms suggestive of hypothyroidism | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Measure FT4 and TSH | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal FT4, Elevated TSH>5.5 | Decresased level of FT4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subclinical hypothyroidism | Elevated TSH > 5.5 | Normal TSH level OR Decreased TSH level < 0.2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Check anti-thyroid autoantibodies and TPOAb | Check TRH | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Increased | Normal | Normal or increased | Decreased | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
•Autoimmune thyroiditis • Resistance to TSH | •Iodine deficeincy •Thyroiditis | •Pituitary related hypothyroidism | •Hypothalamus related hypothyroidism | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differential diagnosis
Disease | History and symptoms | Laboratory findings | Additional findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Goiter | Pain | TSH | Free T4 | T3 | T3RU | Thyroglobin | TRH | TPOAb | |||||
Primary hypothyroidism | Autoimmune | + | +/-
Diffuse |
- | + | - | ↑ | ↓ | Normal or ↓ | Normal | N/↑ | Normal | ↑ | Auto antibodies present
(Anti GAD-65 and anti insulin anti bodies) |
Thyroiditis | + | +/- | + | ↑ | ↓ | Normal or ↓ | Normal | |||||||
Others | - | +/- | - | ↑ | ↓ | Normal or ↓ | ||||||||
Transient hypothyroidism | +/- | + | + | + | - | ↑ | '''↓''' | Normal | Normal | ↑ | Normal | Normal | Acanthosis nigricans | |
Subclinical hypothyroidism | + | + | + | - | + | ↑ | Normal | Normal | Normal | ↑ | Normal | Normal or ↑ | - | |
Central Hypothyroidism | Pituitary | + | + | - | - | - | Normal or ↓ | Normal or ↓ | Normal or ↓ | ↓ | Normal | Normal | Normal | Other hormonal deficiencies |
Hypothalamus | + | + | - | - | - | ↑ | Normal | ↓ | Normal | - | ||||
Resistance to thyroid hormone | - | - | - | - | - | ↑ | ↑ | Normal | Normal | ↑ | Normal | Normal | In hospitalized patients especially in ICU and CCU | |
Steroid therapy | + | - | - | - | + | ↑ | ↑ | Normal | Normal | ↑ | ↑ | N/↑ | Acanthosis nigricans, | |
RTA 1 | - | - | - | + | - | Normal | Normal | ↑ | Normal | ↑ | Normal | Normal | Hypokalemia, nephrolithiasis | |
Glucagonoma | - | - | - | - | - | ↑ | Normal | Normal | Normal | - | Normal | Normal | Necrolytic migratory erythema | |
Cushing syndrome | - | - | - | - | + | ↑ | - | Normal | ↓ | N/↑ | ↑ | Normal | Moon face, obesity, buffalo hump, easy bruisibility |
General feature
Symptoms
Symptoms | Constituitional | HEENT | Neuromuscular | Complications |
---|---|---|---|---|
More common |
|
|
|
|
Less common |
|
|
|
|